Canada Markets open in 2 hrs 7 mins

Paratek Pharmaceuticals, Inc. (PRTK)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.9300+0.0400 (+2.12%)
At close: 04:00PM EDT
1.9200 -0.01 (-0.52%)
Pre-Market: 07:00AM EDT
Full screen
Loading interactive chart...
  • Thomson Reuters StreetEvents

    Q4 2022 Paratek Pharmaceuticals Inc Earnings Call

    Q4 2022 Paratek Pharmaceuticals Inc Earnings Call

  • Zacks

    Paratek Pharmaceuticals (PRTK) Reports Q4 Loss, Tops Revenue Estimates

    Paratek (PRTK) delivered earnings and revenue surprises of -1,300% and 33.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Paratek Pharmaceuticals Announces Full-Year 2022 Revenue of $160.3 Million

    -- NUZYRA® (omadacycline) Generated Net U.S. Sales of $98.7 Million from the Core Commercial Business, a 45% Increase Over the Prior Year -- Continued Progress on the Rare Disease Nontuberculous Mycobacteria (NTM) & BARDA Project BioShield Anthrax Programs BOSTON, March 16, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), today reported financial results and provided an update on corporate activities for the fourth quarter and full-year ended December 31, 2022. Paratek gene